Sourav Roy

Dr. Sourav Roy

1. Department of Biological Sciences, The University of Texas at El Paso, El Paso, TX 79968, USA
+1
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2018 in Annual Review of Entomology
Verified
Journal Article
Closed access
SRSourav Roy
Sourav Roy
TSTusar T. Saha
Tusar T. Saha
Zhen ZouZhen Zou
Zhen Zou
ARAlexander S. Raikhel
Alexander S. Raikhel
The synthesis of vitellogenin and its uptake by maturing oocytes during egg maturation are essential for successful female reproduction. These events are regulated by the juvenile hormones and ecdysteroids and by the nutritional signaling pathway regulated by neuropeptides. Juvenile hormones act as gonadotropins, regulating vitellogenesis in most insects, but ecdysteroids control this process in Diptera and some Hymenoptera and Lepidoptera. The complex crosstalk between the juvenile hormones, ecdysteroids, and nutritional signaling pathways differs distinctly depending on the reproductive strategies adopted by various insects. Molecular studies within the past decade have revealed much about the relationships among, and the role of, these pathways with respect to regulation of insect reproduction. Here, we review the role of juvenile hormones, ecdysteroids, and nutritional signaling, along with that of microRNAs, in regulating female insect reproduction at the molecular level.

7 May 2024 in JCI Insight
Verified
Journal Article
Open access
PDF file
MDManjula Darshi
Manjula Darshi
LKLuxcia Kugathasan
Luxcia Kugathasan
SMSoumya Maity
Soumya Maity
VSVikas S. Sridhar
Vikas S. Sridhar
RFRoman Fernandez
Roman Fernandez
Kumar SharmaKumar Sharma
Kumar Sharma
Lactate elevation is a well-characterized biomarker of mitochondrial dysfunction, but its role in diabetic kidney disease (DKD) is not well defined. Urine lactate was measured in patients with type 2 diabetes (T2D) in 3 cohorts (HUNT3, SMART2D, CRIC). Urine and plasma lactate were measured during euglycemic and hyperglycemic clamps in participants with type 1 diabetes (T1D). Patients in the HUNT3 cohort with DKD had elevated urine lactate levels compared with age- and sex-matched controls. In patients in the SMART2D and CRIC cohorts, the third tertile of urine lactate/creatinine was associated with more rapid estimated glomerular filtration rate decline, relative to first tertile. Patients with T1D demonstrated a strong association between glucose and lactate in both plasma and urine. Glucose-stimulated lactate likely derives in part from proximal tubular cells, since lactate production was attenuated with sodium-glucose cotransporter-2 (SGLT2) inhibition in kidney sections and in SGLT2-deficient mice. Several glycolytic genes were elevated in human diabetic proximal tubules. Lactate levels above 2.5 mM potently inhibited mitochondrial oxidative phosphorylation in human proximal tubule (HK2) cells. We conclude that increased lactate production under diabetic conditions can contribute to mitochondrial dysfunction and become a feed-forward component to DKD pathogenesis.

27 January 2022 in Cancers
Verified
Journal Article
Open access
PDF file
XZXiaojun Zhang
Xiaojun Zhang
MKMazharul Karim
Mazharul Karim
MHMd. Mahedi Hasan
Md. Mahedi Hasan
JHJacob Hooper
Jacob Hooper
SWS M Riajul Wahab
S M Riajul Wahab
TATaslim Al-Hilal
Taslim Al-Hilal
The microfluidic-based cancer-on-a-chip models work as a powerful tool to study the tumor microenvironment and its role in metastasis. The models recapitulate and systematically simplify the in vitro tumor microenvironment. This enables the study of a metastatic process in unprecedented detail. This review examines the development of cancer-on-a-chip microfluidic platforms at the invasion/intravasation, extravasation, and angiogenesis steps over the last three years. The on-chip modeling of mechanical cues involved in the metastasis cascade are also discussed. Finally, the popular design of microfluidic chip models for each step are discussed along with the challenges and perspectives of cancer-on-a-chip models.

12 January 2022 in Cells
Verified
Journal Article
Open access
PDF file
DGDenisse A Gutierrez
Denisse A Gutierrez
LCLisett Contreras
Lisett Contreras
PVPaulina J. Villanueva
Paulina J. Villanueva
EBEdgar Borrego
Edgar Borrego
KMKarla Moran
Karla Moran
Renato AguileraRenato Aguilera
Renato Aguilera
In this study, we identified a novel pyrazole-based derivative (P3C) that displayed potent cytotoxicity against 27 human cancer cell lines derived from different tissue origins with 50% cytotoxic concentrations (CC50) in the low micromolar and nanomolar range, particularly in two triple-negative breast cancer (TNBC) cell lines (from 0.25 to 0.49 µM). In vitro assays revealed that P3C induces reactive oxygen species (ROS) accumulation leading to mitochondrial depolarization and caspase-3/7 and -8 activation, suggesting the participation of both the intrinsic and extrinsic apoptotic pathways. P3C caused microtubule disruption, phosphatidylserine externalization, PARP cleavage, DNA fragmentation, and cell cycle arrest on TNBC cells. In addition, P3C triggered dephosphorylation of CREB, p38, ERK, STAT3, and Fyn, and hyperphosphorylation of JNK and NF-kB in TNBC cells, indicating the inactivation of both p38MAPK/STAT3 and ERK1/2/CREB signaling pathways. In support of our in vitro assays, transcriptome analyses of two distinct TNBC cell lines (MDA-MB-231 and MDA-MB-468 cells) treated with P3C revealed 28 genes similarly affected by the treatment implicated in apoptosis, oxidative stress, protein kinase modulation, and microtubule stability.

14 October 2017 in The Prostate
Verified
Journal Article
Closed access
PDF file
LWLeanne Woods‐Burnham
Leanne Woods‐Burnham
ABAnamika Basu
Anamika Basu
CRChristina K. Cajigas‐Du Ross
Christina K. Cajigas‐Du Ross
ALArthur Love
Arthur Love
CYClayton Yates
Clayton Yates
CCCarlos A Casiano
Carlos A Casiano

12 October 2021 in Cells
Verified
Journal Article
Open access
PDF file
Greisha L. Ortiz-HernandezGreisha L. Ortiz-Hernandez
Greisha L. Ortiz-Hernandez
ESEvelyn S. Sanchez-Hernandez
Evelyn S. Sanchez-Hernandez
POPedro T. Ochoa
Pedro T. Ochoa
CECatherine C. Elix
Catherine C. Elix
HAHossam R. Alkashgari
Hossam R. Alkashgari
CCCarlos A Casiano
Carlos A Casiano
Patients with prostate cancer (PCa) receiving docetaxel chemotherapy invariably develop chemoresistance. The transcription co-activator lens epithelium-derived growth factor p75 (LEDGF/p75), also known as DFS70 and PSIP1, is upregulated in several human cancers, including PCa and promotes resistance to docetaxel and other drugs. The C-terminal region of LEDGF/p75 contains an integrase binding domain (IBD) that tethers nuclear proteins, including the HIV-1 integrase and transcription factors, to active chromatin to promote viral integration and transcription of cellular survival genes. Here, we investigated the contribution of the LEDGF/p75 IBD interactome to PCa chemoresistance. Quantitative immunoblotting revealed that LEDGF/p75 and its IBD-interacting partners are endogenously upregulated in docetaxel-resistant PCa cell lines compared to docetaxel-sensitive parental cells. Using specific human autoantibodies, we co-immunoprecipitated LEDGF/p75 with its endogenous IBD-interacting partners JPO2, menin, MLL, IWS1, ASK1, and PogZ, as well as transcription factors c-MYC and HRP2, in docetaxel-resistant cells, and confirmed their nuclear co-localization by confocal microscopy. Depletion of LEDGF/p75 and selected interacting partners robustly decreased the survival, clonogenicity, and tumorsphere formation capacity of docetaxel-resistant cells. These results implicate the LEDGF/p75 IBD interactome in PCa chemoresistance and could lead to novel therapeutic strategies targeting this protein complex for the treatment of docetaxel-resistant tumors.